cysteamine has been researched along with 2-propanol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allis, B; Cabbat, F; Cohen, G; Dembiec, D; Heikkila, RE; MacNamee, D; Mytilineou, C; Winston, B | 1 |
| Caruso, RC; Gahl, WA; Kaiser-Kupfer, MI; Minkler, DS | 1 |
2 other study(ies) available for cysteamine and 2-propanol
| Article | Year |
|---|---|
Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.
Topics: Animals; Butanols; Cysteamine; Ditiocarb; Ethanol; Free Radicals; Hydrogen Peroxide; Hydroxydopamines; In Vitro Techniques; Iris; Male; Methimazole; Mice; Myocardium; Nerve Endings; Norepinephrine; Oxidation-Reduction; Phenylthiazolylthiourea; Phenylthiourea; Superoxides; Sympathetic Nervous System | 1976 |
Long-term ocular manifestations in nephropathic cystinosis.
Topics: Adolescent; Adult; Child; Cornea; Cysteamine; Cystinosis; Electroretinography; Eye Diseases; Female; Fluorescein Angiography; Humans; Iris; Kidney Diseases; Kidney Transplantation; Lens Capsule, Crystalline; Male; Retina; Visual Acuity | 1986 |